Table 1 Baseline characteristics of patients who underwent THA before and after 1:1 propensity score matchinga
Before match | After match | |||||
|---|---|---|---|---|---|---|
SLE | Control | P value | SLE | Control | P value | |
(n = 617) | (n = 2414) | (n = 325) | (n = 325) | |||
Age | 38.7 ± 12.7 | 56.7 ± 14.5 | < 0.01 | 44.3 ± 12.0 | 46.1 ± 14.0 | 0.07 |
Female | 503 (81.5%) | 999 (41.4%) | < 0.01 | 237 (72.9%) | 237 (72.9%) | 1.00 |
Comorbidities | ||||||
Cerebral vascular accidents | 39 (6.3%) | 247 (10.2%) | < 0.01 | 27 (8.3%) | 17 (5.2%) | 0.11 |
Coronary heart disease | 46 (7.5%) | 412 (17.1%) | < 0.01 | 45 (13.8%) | 35 (10.7%) | 0.09 |
Congestive heart failure | 38 (6.2%) | 120 (5%) | 0.26 | 19 (5.8%) | 11 (3.4%) | 0.13 |
Chronic obstructive pulmonary disease | 59 (9.6%) | 320 (13.3%) | < 0.01 | 43 (13.2%) | 35 (10.8%) | 0.11 |
Diabetes mellitus | 28 (4.5%) | 450 (18.6%) | < 0.01 | 27 (8.3%) | 22 (6.8%) | 0.45 |
Cirrhosis | 7 (1.1%) | 122 (5.1%) | < 0.01 | 3 (0.9%) | 5 (1.5%) | 0.48 |
Chronic kidney disease | 87 (14.1%) | 71 (2.9%) | < 0.01 | 29 (8.9%) | 20 (6.2%) | 0.10 |
Dialysis | 30 (4.9%) | 13 (0.5%) | < 0.01 | 9 (2.8%) | 5 (1.5%) | 0.28 |
CCI_Score | 2.49 ± 1.51 | 1.58 ± 1.78 | < 0.01 | 2.37 ± 1.42 | 1.36 ± 1.71 | < 0.01 |